Vaxxinova acquires Epitopix
PRESS RELEASE WILLMAR, MINNESOTA February 22, 2018 Vaxxinova acquires Epitopix Vaxxinova, an EW-group company with core business focusing on animal health, has concluded an agreement to acquire 100% of the shares in Epitopix, a US based animal health company specialized in poultry and livestock biologicals and founder of SRP® technology. The transaction will be concluded by […]
Read more →
New at Vaxxinova diagnostics
PCR profile PCV2/PCV3 – At Vaxxinova, a new real-time PCR assay for the simultaneous detection of PCV2 and PCV3 could be established. The PCR has a high analytical sensitivity and specificity. Our results confirm the presence of PCV3 in Germany. Frequently, double infections of PCV2 and PCV3 have been detected, especially in cases of PMWS […]
Read more →
Vaxxinova, headquartered in The Netherlands, acquires Laboratório Biovet
Vargem Grande Paulista, São Paulo, February 1, 2018. Vaxxinova, a subsidiary of the EW Group, has acquired Laboratório Biovet, a Brazilian company with 60 years of commitment to the animal health industry. Biovet was founded in 1957 by veterinarian René Corrêa, and has remained a family-owned company since then. The company is strongly positioned in […]
Read more →
Vaxxinova
Vaxxinova is committed to disease prevention in livestock. We aim to provide a complete set of vaccines and diagnostic services, supported by our global R&D network. Vaxxinova believes in ‘business without borders’, and long term partnerships with livestock veterinarians and animal health professionals. We work together in disease prevention and livestock performonce improvement programs. Our technical teams can advise you on our products and services.